Eptifibatide (Akorn, Inc.)
Welcome to the PulseAid listing for the Eptifibatide drug offered from Akorn, Inc.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Akorn, Inc. |
| NON-PROPRIETARY NAME: | Eptifibatide |
| SUBSTANCE NAME: | EPTIFIBATIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-18 |
| END MARKETING DATE: | 0000-00-00 |
Eptifibatide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Eptifibatide from Akorn, Inc. |
| LABELER NAME: | Akorn, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2017-04-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17478-902_bde330a9-54d1-495d-8b67-4030241fc79f |
| PRODUCT NDC: | 17478-902 |
| APPLICATION NUMBER: | ANDA204589 |
Other EPTIFIBATIDE Pharmaceutical Manufacturers / Labelers:
